Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals

Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals

Abstract Background Serology testing is explored for epidemiological research and to inform individuals after suspected infection. During the coronavirus disease 2019 (COVID-19) pandemic, frontline healthcare professionals (HCP) may be at particular risk for infection. No longitudinal data on functi...

Full description

Bibliographic Details
Main Authors: Georg M. N. Behrens, Anne Cossmann, Metodi V. Stankov, Bianca Schulte, Hendrik Streeck, Reinhold Förster, Berislav Bosnjak, Stefanie Willenzon, Anna-Lena Boeck, Anh Thu Tran, Thea Thiele, Theresa Graalmann, Moritz Z. Kayser, Anna Zychlinsky Scharff, Christian Dopfer, Alexander Horke, Isabell Pink, Torsten Witte, Martin Wetzke, Diana Ernst, Alexandra Jablonka, Christine Happle
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-09-01
Series:Infectious Diseases and Therapy
Subjects:
Coronavirus
COVID-19
Healthcare professionals
Humoral immunity
Infection
Pandemic
Online Access:https://doi.org/10.1007/s40121-020-00334-1

Internet

https://doi.org/10.1007/s40121-020-00334-1

Similar Items